Neurosense Therapeutics Ltd
Change company Symbol lookup
Select an option...
NRSN Neurosense Therapeutics Ltd
QLGN Qualigen Therapeutics Inc
JOFF JOFF Fintech Acquisition Corp
IR Ingersoll Rand Inc
TGT Target Corp
CCLP CSI Compressco LP
BIOT Biotech Acquisition Co
XNXNX Nuveen New York Select Tax Free Income Portfolio
DHHC DiamondHead Holdings Corp
WFC Wells Fargo & Co
Go

Health Care : Biotechnology |
Based in Israel
Company profile

NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Postmarket

Last Trade
Delayed
$1.62
-0.026 (-1.58%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.65
Day's Change
0.016 (0.98%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.66
Day's Low
1.60
Volume
(Average)
Volume:
13,585

10-day average volume:
12,984
13,585
  • Prev Close
    1.63
  • Today's Open
    1.66
  • Day's Range
    1.60-1.66
  • Avg Vol (10-day)
    13.0K
  • Last (time)
    3:49p ET 12/07/22
  • Last (size)
    5
  • 52-Wk Range
    1.23 - 8.18
    LowHigh
  • (03/21/22 - 05/12/22)
    33.82%
  • 183.6%
  • Market Cap
    19.2M
  • Shares Outstanding
    11.7M
  • --
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 0.63
  • (% of float 11/15/22)
    0.35

Latest News

December 01, 2022
9:05 am ET
PR Newswire
November 16, 2022
9:34 am ET
PR Newswire
November 15, 2022
8:30 am ET
PR Newswire
October 27, 2022
8:50 am ET
PR Newswire
October 21, 2022
9:25 am ET
PR Newswire
October 18, 2022
8:33 am ET
PR Newswire
October 12, 2022
8:30 am ET
PR Newswire
September 29, 2022
8:30 am ET
PR Newswire
September 21, 2022
8:51 am ET
PR Newswire
September 20, 2022
8:45 am ET
PR Newswire
September 19, 2022
9:14 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.